About Glut1 Deficiency
Glucose Transporter Type 1 Deficiency Syndrome
Glut1 Deficiency, G1D, Glut1 DS, or De Vivo Disease
Glucose Transporter Type 1 Deficiency Syndrome is a genetic disorder that impairs brain metabolism. Glucose isn’t transported properly into the brain, which leaves it starving for the metabolic fuel it needs to grow, develop, and function the way it should. Glut1 Deficiency is caused by mutations in the SLC2A1 gene, which is responsible for regulating production of the glucose transporter protein type 1 (Glut1). The Glut1 protein transports glucose into cells, between cells, and across the blood-brain barrier. Glut1 is the principal transporter of glucose, the primary source of energy, across the blood-brain barrier and is key in supplying glucose to the cells of the central nervous system. More than 100 different types of mutations and deletions of this gene have been found to date in Glut1 Deficiency patients, and approximately 10-15% of patients do not show a genetic mutation.
The impaired glucose transport associated with Glut1 Deficiency causes an array of symptoms which may vary considerably from one patient to another and can change and evolve over time. Some of the most common signs and symptoms may include seizures, unusual eye-head movements in infancy, movement disorders, speech and language disorders, and developmental delays. Not all patients experience all symptoms, especially in the milder cases. There are currently a few hundred patients diagnosed worldwide, but experts believe there are thousands more yet to be discovered.
There is currently no cure for Glut1 Deficiency. The recommended standard treatment is a ketogenic diet, which helps improve most symptoms for most patients, even in adulthood. A ketogenic diet gives the brain an alternate source of energy and helps optimize brain growth and development.
Could it be Glut1 Deficiency?
The hallmark symptoms of classical Glut1 Deficiency are seizures (approximately 90% of patients), a complex movement disorder, developmental delay and intellectual disability, and speech/language impairments. Not all patients experience all symptoms, and there is a great deal of variance across a wide spectrum in both the combination and severity of symptoms from one patient to another. Symptoms may also change over time as patients age.
Suggestive symptoms seen in many Glut1 Deficiency patients:
(please see our Key Terms resource for a more complete list with definitions)
Other conditions sometimes diagnosed in patients with Glut1 Deficiency:
Diagnosing Glut1 Deficiency
Glut1 Deficiency should be considered and tested in any patient with suggestive symptoms. If in doubt, rule it out - a diagnosis and proper treatment is life-changing for most patients.
Diagnostic Criteria: Symptoms, Cerebrospinal Fluid Testing, Genetic Testing
The combination of suggestive clinical symptoms and the characteristic CSF findings indicate a Glut1 Deficiency diagnosis, even in the absence of an identified SLC2A1 mutation.
Distinct patterns of brain glucose uptake on PET scans and specialized red blood cell uptake assays are also useful in the absence of an otherwise clear diagnosis but might be available in specialized centers only.
Brochures
Professional Guide
Diagnostic Protocol
Additional Resources
The impaired glucose transport associated with Glut1 Deficiency causes an array of symptoms which may vary considerably from one patient to another and can change and evolve over time. Some of the most common signs and symptoms may include seizures, unusual eye-head movements in infancy, movement disorders, speech and language disorders, and developmental delays. Not all patients experience all symptoms, especially in the milder cases. There are currently a few hundred patients diagnosed worldwide, but experts believe there are thousands more yet to be discovered.
There is currently no cure for Glut1 Deficiency. The recommended standard treatment is a ketogenic diet, which helps improve most symptoms for most patients, even in adulthood. A ketogenic diet gives the brain an alternate source of energy and helps optimize brain growth and development.
Could it be Glut1 Deficiency?
The hallmark symptoms of classical Glut1 Deficiency are seizures (approximately 90% of patients), a complex movement disorder, developmental delay and intellectual disability, and speech/language impairments. Not all patients experience all symptoms, and there is a great deal of variance across a wide spectrum in both the combination and severity of symptoms from one patient to another. Symptoms may also change over time as patients age.
Suggestive symptoms seen in many Glut1 Deficiency patients:
(please see our Key Terms resource for a more complete list with definitions)
- paroxysmal exercise-induced dystonia/dyskinesia (PED) (movement episodes triggered by exercise)
- early onset absence seizures before the age of 3
- treatment resistant seizures/epilepsy at any age
- movement and balance issues (ataxia, dystonia, chorea, tremor, gait abnormalities, and others)
- fluctuation of symptoms with hunger, fatigue, heat, illness, anxiety, stress, excitement
- symptoms worse just after waking in the morning
- symptom improvement after eating
- opsoclonus-like darting and dancing eye/head movements in first two years of life (aberrant gaze saccades or intermittent involuntary gaze)
- paroxysmal neurological symptoms (transient or episodic - not there all the time)
(seizures, movement disturbances, hemiplegia episodes, migraines, energy levels, confusion, mood) - speech difficulties
- Dystonia 9 and Dystonia 18 are associated with the SLC2A1 gene and are considered part of the phenotypic spectrum
- developmental delays
- intellectual disabilities
Other conditions sometimes diagnosed in patients with Glut1 Deficiency:
- epilepsy
- cerebral palsy
- ataxia
- dystonia
- autism
- hemolytic anemia
- ADHD
- alternating hemiplegia of childhood
Diagnosing Glut1 Deficiency
Glut1 Deficiency should be considered and tested in any patient with suggestive symptoms. If in doubt, rule it out - a diagnosis and proper treatment is life-changing for most patients.
Diagnostic Criteria: Symptoms, Cerebrospinal Fluid Testing, Genetic Testing
- suggestive symptoms
- low CSF glucose (typically below 60 mg/dL) in the presence of normal blood glucose
- CSF glucose to blood glucose ratio typically below .4
- low or low-normal CSF lactate
- genetic abnormalities in the SLC2A1 gene (found in 85-90% of patients)
The combination of suggestive clinical symptoms and the characteristic CSF findings indicate a Glut1 Deficiency diagnosis, even in the absence of an identified SLC2A1 mutation.
Distinct patterns of brain glucose uptake on PET scans and specialized red blood cell uptake assays are also useful in the absence of an otherwise clear diagnosis but might be available in specialized centers only.
Brochures
Professional Guide
Diagnostic Protocol
Additional Resources
